Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +5.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.66 | N/A | +5.56% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on their product performance. They emphasized their commitment to innovation and customer satisfaction.
Management highlighted strong performance in key product categories.
They expressed confidence in maintaining market share despite competitive pressures.
The earnings report shows that Prestige Consumer HE exceeded EPS expectations, which likely contributed to the stock's 1.51% increase. However, the lack of revenue data and guidance may leave investors cautious. Overall, the positive EPS surprise indicates some resilience in the company's performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SBA COMMUNICATIONS C Class A REIT
Jul 31, 2017